Array Biopharma (ARRY) Announces $100M Common Stock Offering
Get Alerts ARRY Hot Sheet
Join SI Premium – FREE
Array BioPharma (Nasdaq: ARRY) announced that it has commenced an underwritten public offering of $100 million of shares of its common stock. Array BioPharma also intends to grant the underwriters a 30-day option to purchase up to an additional $15 million of shares of its common stock offered in the public offering. All of the shares in the offering are to be sold by Array BioPharma.
J.P. Morgan Securities LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AGBA Group Holding (AGBA) selling off into close, down over 17%
- Tesla (TSLA) soars on Q1 print
- T-Mobile (TMUS) and EQT Announce JV to Acquire Lumos
Create E-mail Alert Related Categories
Equity Offerings, Momentum Movers, Trader TalkRelated Entities
JPMorgan, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!